Non-Hodgkin Lymphoma – Pipeline Review, H1 2017 provides Comprehensive Information on the Therapeutics under Development

ResearchMoz added Latest Research Report titled ” Non-Hodgkin Lymphoma – Pipeline Review, H1 2017 ” to it’s Large Report database.

Non-Hodgkin Lymphoma – Pipeline Review, H1 2017

Summary

Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Non-Hodgkin Lymphoma – Pipeline Review, H1 2017, provides an overview of the Non-Hodgkin Lymphoma (Oncology) pipeline landscape.

Non-Hodgkin lymphoma (also known as non-Hodgkin lymphoma, NHL, or sometimes just lymphoma) is a cancer that starts in cells called lymphocytes, which are part of the bodys immune system. Symptoms depend on what area of the body is affected by the cancer and how fast the cancer is growing.Symptoms may include night sweats (soaking the bed sheets and pajamas even though the room temperature is not too hot),fever and chills that come and go, itching, swollen lymph nodes in the neck, underarms, groin, or other areas, weight loss, coughing or shortness of breath if the cancer affects the thymus gland or lymph nodes in the chest, putting pressure on the windpipe (trachea) or other airway, abdominal pain or swelling, leading to loss of appetite, constipation, nausea, and vomiting and headache, concentration problems, personality changes, or seizures if the cancer affects the brain. Treatment includes surgery, radiation therapy and chemotherapy.

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=1135786

Report Highlights

Global Markets Direct’s Pharmaceutical and Healthcare latest pipeline guide Non-Hodgkin Lymphoma – Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Non-Hodgkin Lymphoma (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Non-Hodgkin Lymphoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Non-Hodgkin Lymphoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 6, 2, 28, 137, 124, 5, 123, 18 and 3 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 15, 17, 16 and 4 molecules, respectively.

Read All Pharmaceutical Market Research Reports @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html

Table of Contents

Table of Contents 2
Introduction 11
Non-Hodgkin Lymphoma – Overview 12
Non-Hodgkin Lymphoma – Therapeutics Development 13
Non-Hodgkin Lymphoma – Therapeutics Assessment 85
Non-Hodgkin Lymphoma – Companies Involved in Therapeutics Development 111
Non-Hodgkin Lymphoma – Drug Profiles 233
Non-Hodgkin Lymphoma – Dormant Projects 1656
Non-Hodgkin Lymphoma – Discontinued Products 1676
Non-Hodgkin Lymphoma – Product Development Milestones 1684
Appendix 1692

List of Tables
Number of Products under Development for Non-Hodgkin Lymphoma, H1 2017 60
Number of Products under Development by Companies, H1 2017 62
Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017 63
Number of Products under Development by Companies, H1 2017 (Contd..2), H1 2017 64
Number of Products under Development by Companies, H1 2017 (Contd..3), H1 2017 65
Number of Products under Development by Companies, H1 2017 (Contd..4), H1 2017 66
Number of Products under Development by Companies, H1 2017 (Contd..5), H1 2017 67
Number of Products under Development by Companies, H1 2017 (Contd..6), H1 2017 68
Number of Products under Development by Companies, H1 2017 (Contd..7), H1 2017 69
Number of Products under Development by Companies, H1 2017 (Contd..8), H1 2017 70

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States – 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/

%d bloggers like this: